Vanguard Total Bond Market Index Fund (BND) vs Merck & Co., Inc. (MRK)

Vanguard Total Bond Market ETF is an exchange-traded fund focused on the broad U.S. investment-grade bond market. It provides access to a diversified portfolio of fixed-income securities and is commonly used for income generation, liquidity management, or duration positioning. Its performance is influenced by interest-rate changes, credit spreads, issuer quality, maturity profile, reinvestment yields, and fund expenses. Bond ETFs can still fluctuate in value, especially when rates or credit conditions move quickly.

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.